ATE548446T1 - Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten - Google Patents

Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten

Info

Publication number
ATE548446T1
ATE548446T1 AT06803596T AT06803596T ATE548446T1 AT E548446 T1 ATE548446 T1 AT E548446T1 AT 06803596 T AT06803596 T AT 06803596T AT 06803596 T AT06803596 T AT 06803596T AT E548446 T1 ATE548446 T1 AT E548446T1
Authority
AT
Austria
Prior art keywords
protein
animal
purification
production
animal components
Prior art date
Application number
AT06803596T
Other languages
English (en)
Inventor
Nandu Deorkar
Wei Guo
Steve Magee
Original Assignee
Avantor Performance Mat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantor Performance Mat Inc filed Critical Avantor Performance Mat Inc
Application granted granted Critical
Publication of ATE548446T1 publication Critical patent/ATE548446T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06803596T 2005-09-20 2006-09-14 Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten ATE548446T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71875905P 2005-09-20 2005-09-20
PCT/US2006/035837 WO2007035410A1 (en) 2005-09-20 2006-09-14 Protein a production and purification without using animal derived components

Publications (1)

Publication Number Publication Date
ATE548446T1 true ATE548446T1 (de) 2012-03-15

Family

ID=37565573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06803596T ATE548446T1 (de) 2005-09-20 2006-09-14 Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten

Country Status (16)

Country Link
US (1) US20100261842A1 (de)
EP (1) EP1926811B1 (de)
JP (1) JP2009508950A (de)
KR (2) KR20080052599A (de)
CN (2) CN101268182A (de)
AT (1) ATE548446T1 (de)
AU (2) AU2006292700A1 (de)
BR (2) BRPI0616199A2 (de)
CA (2) CA2623176A1 (de)
IL (2) IL190088A (de)
MY (1) MY185597A (de)
NO (2) NO20081881L (de)
NZ (2) NZ566871A (de)
PL (1) PL1926811T3 (de)
TW (2) TW200801180A (de)
WO (2) WO2007035341A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
CN101921320A (zh) * 2010-07-15 2010-12-22 大连理工大学 一种重组蛋白a的分离纯化方法
CN102731631B (zh) * 2011-04-07 2014-04-30 上海荣君生物医药科技有限公司 蛋白a的亲和分离材料及应用
KR101367409B1 (ko) * 2011-12-29 2014-02-25 대상 주식회사 백탁이 개선된 사이클로덱스트린 함유 액상 조성물의 제조방법
EP3497117B1 (de) * 2016-08-11 2024-01-24 Navigo Proteins GmbH Novel alkaline stable immunoglobulin-binding proteins
CN106977591B (zh) * 2017-05-04 2020-05-05 广州康盛生物科技股份有限公司 一种分离纯化重组葡萄球菌蛋白a的方法
EP3521304B9 (de) 2018-02-01 2023-10-04 Repligen Corporation Fc-bindungsproteine mit cystein in der c-terminalen helikalen region
CA3072288A1 (en) 2017-08-07 2019-02-14 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
CN113150120B (zh) * 2021-05-21 2022-09-30 江南大学 发酵液中猪肌红蛋白的分离纯化方法
CN114773454B (zh) * 2022-04-27 2022-11-29 广州蕊特生物科技有限公司 从马心中提取肌红蛋白的提取与纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE91152T1 (de) * 1988-07-22 1993-07-15 Imre Corp Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
US6555661B1 (en) * 1997-08-25 2003-04-29 Anthony R. Torres Simple, environmentally benign, method for purifying protein A
US5902722A (en) * 1997-12-05 1999-05-11 The Perkin-Elmer Corporation Method of detecting organisms in a sample
PL369446A1 (en) * 2001-09-25 2005-04-18 Immuno-Biological Laboratories Co, Ltd. Recombinant anti-osteopontin antibody and use thereof
AU2002364509A1 (en) * 2001-11-30 2003-06-17 Emory University Factor viii c2 domain variants
CA2469815C (en) * 2001-12-21 2011-05-03 Immunex Corporation Methods for purifying protein
US20040235139A1 (en) * 2002-12-23 2004-11-25 Demain Arnold L. Clostridium difficile culture and toxin production methods
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof

Also Published As

Publication number Publication date
CA2623176A1 (en) 2007-03-29
EP1926811B1 (de) 2012-03-07
TW200804412A (en) 2008-01-16
IL190092A0 (en) 2008-08-07
MY185597A (en) 2021-05-24
NO20081881L (no) 2008-04-18
AU2006292583A1 (en) 2007-03-29
CN101268181A (zh) 2008-09-17
IL190088A (en) 2011-12-29
US20100261842A1 (en) 2010-10-14
JP2009508950A (ja) 2009-03-05
TW200801180A (en) 2008-01-01
CN101268182A (zh) 2008-09-17
PL1926811T3 (pl) 2012-08-31
NO20081882L (no) 2008-04-18
KR20080052599A (ko) 2008-06-11
BRPI0616201A2 (pt) 2011-06-14
NZ566873A (en) 2011-07-29
BRPI0616199A2 (pt) 2011-06-14
EP1926811A1 (de) 2008-06-04
WO2007035410A1 (en) 2007-03-29
NZ566871A (en) 2011-09-30
IL190088A0 (en) 2008-08-07
AU2006292583B2 (en) 2011-11-10
WO2007035341A1 (en) 2007-03-29
KR20080065590A (ko) 2008-07-14
AU2006292700A1 (en) 2007-03-29
CA2622542A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
IL190088A0 (en) Protein a production and purification without using animal derived components
ATE415478T1 (de) Fermentationsverfahren zur herstellung von l- aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
MX2012007497A (es) Metodo para modificacion de polipeptidos para purificar multimeros de polipeptido.
ATE334218T1 (de) Verfahren zur gleichzeitigen herstellung von xylitol und ethanol
ATE512990T1 (de) Verfahren zur herstellung von gereinigten beta-(1,3)-d-glucanen
ATE473224T1 (de) Verfahren zur herstellung von nebivolol
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
ATE371014T1 (de) Verfahren zur herstellung von biologischen substanzen durch perfusionskultivierung von suspendierten tierischen zellen
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
ATE401300T1 (de) Verfahren zur herstellung von valsartan und vorstufen davon
WO2006024387A3 (de) Biphenylthiazolcarboxamide
ATE522543T1 (de) Verfahren zur herstellung von reifem, rekombinantem milben-i-allergen
MY140061A (en) Improved method for the production of ramipril
ATE525911T1 (de) Verfahren zur verbesserung der fleischqualität von fisch,proteinhydrolysat und verfahren zur herstellung eines proteinhydrolysats
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
ATE384790T1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
ATE388154T1 (de) Kristalline form von cefdinir-ammoniumsalz als zwischenprodukt für die herstellung von reinem cefdinir
ATE486999T1 (de) Vorrichtung und verfahren zur herstellung von cellulosebasierten produkten
ATE437220T1 (de) Verwendung von interleukin-17 für oozytenreifung
DE602005026854D1 (de) Verfahren zur herstellung von hohen niveaus von interferon-beta
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin
ATE451345T1 (de) Verfahren zur herstellung von optisch aktiven 3- phenylpropionsäurederivaten und folgeprodukte davon